A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

Clinical trial NCT06887348 · RECRUITING

Trial details

NCT number: NCT06887348
Sponsor: Replimune, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Melanoma Metastatic Melanoma Advanced Solid Tumor Hepatocellular Carcinoma

Start date: 2025-12-12
Primary completion: 2030-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.